Oestrogen receptor-β CA repeat polymorphism is associated with incidence of colorectal cancer among females

Histopathology

Volumn 59, Issue 2, 2011, Pages 216-224

  Honma, Naoko ^a   Arai, Tomio ^b   Takubo, Kaiyo ^a   Younes, Mamoun ^c   Tanaka, Noriko ^d,e   Mieno, Makiko Naka ^f   Tamura, Kohei ^g   Ikeda, Shinobu ^g   Sawabe, Motoji ^b   Muramatsu, Masaaki ^g  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b Tokyo Metropolitan Institute of Gerontology   (Japan)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f JICHI MEDICAL UNIVERSITY   (Japan)

^g TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

CA repeat polymorphism; Colorectal cancer; Female; Oestrogen receptor

Indexed keywords

DINUCLEOTIDE; ESTROGEN RECEPTOR BETA;

ARTICLE; COLORECTAL CANCER; DINUCLEOTIDE REPEAT; DISEASE ASSOCIATION; DNA EXTRACTION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; JAPAN; KIDNEY CORTEX; MALE; MEDICAL RECORD REVIEW; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEX DIFFERENCE;

ADENOCARCINOMA; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DINUCLEOTIDE REPEATS; ESTROGEN RECEPTOR BETA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; POLYMORPHISM, GENETIC;

EID: 80052192520     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03914.x     Document Type: Article

References (32)

1. Avital S, Kashtan H, Hadad R, Werbin N. Survival of colorectal carcinoma in the elderly. A prospective study of colorectal carcinoma and a five-year follow-up. Dis. Colon Rectum 1997; 40; 523-529.
2. Yancik R, Wesley MN, Ries LA et al. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer 1998; 82; 2123-2134.
3. Kakizoe T, Yamaguchi N, Mitsuhashi F, Koshiji M, Oshima A, Ohtaka M eds. Cancer statistics in Japan 2008. Tokyo: Foundation for Promotion of Cancer Research, 2008.
4. Dickson RB, Stancel GM. Estrogen receptor-mediated processes in normal and cancer cells. J. Natl Cancer Inst. Monogr. 2000; 27; 135-145.
5. Song RX, Santen RJ. Apoptotic action of estrogen. Apoptosis 2003; 8; 55-60.
6. Bosland MC. The role of steroid hormones in prostate carcinogenesis. J. Natl Cancer Inst. Monogr. 2000; 27; 39-66.
7. Collins J, Donner A, Allen LH, Adams O. Oestrogen use and survival in endometrial cancer. Lancet 1980; 2; 961-964.
8. Dowsett M, Archer C, Assersohn L et al. Clinical studies of apoptosis and proliferation in breast cancer. Endocr. Relat. Cancer 1999; 6; 25-28.
9. Honma N, Horii R, Iwase T et al. Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy. J. Clin. Oncol. 2008; 26; 3727-3734.
10. Kennelly R, Kavanagh DO, Hogan AM, Winter DC. Oestrogen and the colon: potential mechanisms for cancer prevention. Lancet Oncol. 2008; 9; 385-391.
11. Witte D, Chirala M, Younes A, Li Y, Younes M. Estrogen receptor beta is expressed in human colorectal adenocarcinoma. Hum. Pathol. 2001; 32; 940-944.
12. Wong NA, Malcomson RD, Jodrell DI, Groome NP, Harrison DJ, Saunders PT. ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates. J. Pathol. 2005; 207; 53-60.
13. Jassam N, Bell SM, Speirs V, Quirke P. Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. Oncol. Rep. 2005; 14; 17-21.
14. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl Acad. Sci. USA 1996; 93; 5925-5930.
15. Moore JT, McKee DD, Slentz-Kesler K et al. Cloning and characterization of human estrogen receptor beta isoforms. Biochem. Biophys. Res. Commun. 1998; 247; 75-78.
16. Ogawa S, Inoue S, Watanabe T et al. Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human. Nucleic Acids Res. 1998; 26; 3505-3512.
17. Weihua Z, Andersson S, Cheng G, Simpson ER, Warner M, Gustafsson JA. Update on estrogen signaling. FEBS Lett. 2003; 546; 17-24.
18. Ogawa S, Emi M, Shiraki M, Hosoi T, Ouchi Y, Inoue S. Association of estrogen receptor beta (ESR2) gene polymorphism with blood pressure. J. Hum. Genet. 2000; 45; 327-330.
19. Ogawa S, Hosoi T, Shiraki M et al. Association of estrogen receptor beta gene polymorphism with bone mineral density. Biochem. Biophys. Res. Commun. 2000; 269; 537-541.
20. Slattery ML, Sweeney C, Murtaugh M et al. Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer. Cancer Epidemiol. Biomarkers Prev. 2005; 14; 2936-2942.
21. Takeo C, Negishi E, Nakajima A et al. Association of cytosine-adenine repeat polymorphism of the estrogen receptor-beta gene with menopausal symptoms. Gend. Med. 2005; 2; 96-105.
22. Takeo C, Ugai K, Araki J et al. Pharmacogenetics of hormone replacement therapy for climacteric symptoms. Biochem. Biophys. Res. Commun. 2008; 374; 604-608.
23. Tsukamoto K, Inoue S, Hosoi T, Orimo H, Emi M. Isolation and radiation hybrid mapping of dinucleotide repeat polymorphism at the human estrogen receptor beta locus. J. Hum. Genet. 1998; 43; 73-74.
24. Forsell C, Enmark E, Axelman K et al. Investigations of a CA repeat in the oestrogen receptor beta gene in patients with Alzheimer's disease. Eur. J. Hum. Genet. 2001; 9; 802-804.
25. Sobin LH, Wittekind C eds. TNM classification of malignant tumours. Wilmington: Wiley-Liss, 2002.
26. Mann S, Laucirica R, Carlson N et al. Estrogen receptor beta expression in invasive breast cancer. Hum. Pathol. 2001; 32; 113-118.
27. Iacopetta B. Are there two sides to colorectal cancer? Int. J. Cancer 2002; 101; 403-408.
28. Arai T, Sugai T, Kasahara I et al. Age-related alteration in the association of microsatellite instability with absent hMLH1 expression and histological types of colorectal carcinoma. Pathol. Int. 2006; 56; 597-603.
29. Weyant MJ, Carothers AM, Mahmoud NN et al. Reciprocal expression of ERalpha and ERbeta is associated with estrogen-mediated modulation of intestinal tumorigenesis. Cancer Res. 2001; 61; 2547-2551.
30. Slattery ML, Potter JD, Curtin K et al. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res. 2001; 61; 126-130.
31. Arai T, Esaki Y, Sawabe M, Honma N, Nakamura K, Takubo K. Hypermethylation of the hMLH1 promoter with absent hMLH1 expression in medullary-type poorly differentiated colorectal adenocarcinoma in the elderly. Mod. Pathol. 2004; 17; 172-179.
32. Arai T, Kasahara I, Sawabe M et al. Microsatellite-unstable mucinous colorectal carcinoma occurring in the elderly: comparison with medullary type poorly differentiated adenocarcinoma. Pathol. Int. 2007; 57; 205-212.